SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-008590
Filing Date
2020-08-06
Accepted
2020-08-06 16:09:03
Documents
40
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnpr_form10q06302020.htm 10-Q 688636
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-1.htm EX-31 11719
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31-2.htm EX-31 11528
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32-1.htm EX-32 9945
  Complete submission text file 0001654954-20-008590.txt   2168745

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mono-20200630.xml EX-101.INS 268294
6 XBRL TAXONOMY EXTENSION SCHEMA mono-20200630.xsd EX-101.SCH 18576
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20200630_cal.xml EX-101.CAL 26070
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20200630_def.xml EX-101.DEF 52921
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20200630_lab.xml EX-101.LAB 157418
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20200630_pre.xml EX-101.PRE 122184
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 201081656
SIC: 2834 Pharmaceutical Preparations